secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2022-10-27T23:59:59+00:00
Accession:  0001493152-22-029729
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce Biosciences implements 1-for-20 reverse stock split effective Oct 28, 2022
--------------------------------------------------------------------------------

- Reverse split ratio of 1-for-20; effective 12:01 am October 28, 2022.
- No change to authorized shares, par value, or voting rights; fractional shares rounded up to whole share.
- Exercise prices and shares issuable under warrants, options, and RSUs adjusted proportionally.
- New CUSIP number 293602207; trading symbol ENSC remains on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315222029729/0001493152-22-029729-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315222029729/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-029729

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer